{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:31:48Z","timestamp":1790285508809,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81601773"],"award-info":[{"award-number":["81601773"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Shandong Province, China","award":["ZR2015JL026"],"award-info":[{"award-number":["ZR2015JL026"]}]},{"name":"Natural Science Foundation of Shandong Province, China","award":["ZR2012HL15"],"award-info":[{"award-number":["ZR2012HL15"]}]},{"name":"Science and Technology Development Plan of traditional Chinese Medicine of Shandong Province, China","award":["2015-259"],"award-info":[{"award-number":["2015-259"]}]},{"name":"Science and Technology Development Planof Taian City, China","award":["201540707"],"award-info":[{"award-number":["201540707"]}]},{"name":"Taishan Scholars program of Shandong Province, China","award":["ts201511056"],"award-info":[{"award-number":["ts201511056"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.vaccine.2018.09.069","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T01:32:56Z","timestamp":1539221576000},"page":"7095-7104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice"],"prefix":"10.1016","volume":"36","author":[{"given":"Zhenjie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaopeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8717-2942","authenticated-orcid":false,"given":"Weifeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.09.069_b0005","doi-asserted-by":"crossref","DOI":"10.1145\/2818302","article-title":"Clinical features for mild hand, foot and mouth disease in China","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.09.069_b0010","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMoa065954","article-title":"Neurodevelopment and cognition in children after enterovirus 71 infection","volume":"356","author":"Chang","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.09.069_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052432","article-title":"Comparative genomic analysis of coxsackievirus A6 strains of different clinical disease entities","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.09.069_b0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3201\/eid1802.111147","article-title":"Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011","volume":"18","author":"Fujimoto","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.09.069_b0025","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1111\/j.1469-0691.2012.03789.x","article-title":"Outbreak of hand, foot and mouth disease\/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study","volume":"18","author":"Mirand","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2018.09.069_b0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/1469-0691.12361","article-title":"Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated with hand, foot and mouth disease in Spain","volume":"3","author":"Cabrerizo","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2018.09.069_b0035","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/jpc.12708","article-title":"Outbreak of variant hand-foot-and-mouth disease caused by coxsackievirus A6 in Auckland, New Zealand","volume":"10","author":"Hayman","year":"2014","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2018.09.069_b0040","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3201\/eid1904.121666","article-title":"Hand, foot, and mouth disease caused by coxsackievirus A6, Thailand, 2012","volume":"19","author":"Puenpa","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.09.069_b0045","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1586\/14787210.2015.1058156","article-title":"Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide","volume":"13","author":"Bian","year":"2015","journal-title":"Exp Rev Anti-infective Therapy"},{"key":"10.1016\/j.vaccine.2018.09.069_b0050","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/jmv.24151","article-title":"Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of coxsackieviruses A10","volume":"87","author":"Yang","year":"2015","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2018.09.069_b0055","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1017\/S0950268815002137","article-title":"Basic reproduction number of coxsackievirus type A6 and A16 and enterovirus 71: estimates from outbreaks of hand, foot and mouth disease in Singapore, a tropical city-state","volume":"144","author":"Lim","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2018.09.069_b0060","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3201\/eid2211.160590","article-title":"Ambulatory pediatric surveillance of hand, foot and mouth disease as signal of an outbreak of coxsackievirus A6 Infections, France, 2014\u20132015","volume":"22","author":"Mirand","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.09.069_b0065","article-title":"A mild phenotype of hand, foot and mouth disease caused by Coxsackievirus A6","author":"Hattori","year":"2017","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.vaccine.2018.09.069_b0070","doi-asserted-by":"crossref","first-page":"45630","DOI":"10.1038\/srep45630","article-title":"Epidemiology of 45,616 suspect cases of Hand, Foot and Mouth Disease in Chongqing, China, 2011\u20132015","volume":"7","author":"Tao","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2018.09.069_b0075","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1128\/JVI.00422-15","article-title":"Crystal structures of yeast-produced enterovirus 71 and enterovirus 71\/coxsackievirus A16 chimeric virus-like particles provide the structural basis for novel vaccine design against hand-foot-and-mouth disease","volume":"89","author":"Lyu","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.09.069_b0080","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.09.069_b0085","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1586\/14760584.2015.1001750","article-title":"Polio endgame: the global introduction of inactivated polio vaccine","volume":"14","author":"Patel","year":"2015","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.vaccine.2018.09.069_b0090","article-title":"Protective efficacies of formaldehyde-inactivated whole-virus vaccine and antivirals in a murine model of coxsackievirus A10 infection","volume":"91","author":"Zhang","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.09.069_b0095","article-title":"A Neonatal murine model of Coxsackievirus A6 infection for evaluation of antiviral and vaccine efficacy","volume":"91","author":"Zhang","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.09.069_b0100","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2014.03.012","article-title":"A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses","volume":"32","author":"Cai","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.069_b0105","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.3390\/v7112916","article-title":"Efficacy of a trivalent hand, foot, and mouth disease vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice","volume":"7","author":"Caine","year":"2015","journal-title":"Viruses"},{"issue":"41","key":"10.1016\/j.vaccine.2018.09.069_b0110","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1016\/j.vaccine.2016.08.033","article-title":"Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge","volume":"34","author":"Shen","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.069_b0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1128\/JVI.01848-13","article-title":"Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms","volume":"88","author":"Ye","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.09.069_b0120","doi-asserted-by":"crossref","first-page":"11967","DOI":"10.1128\/JVI.00902-12","article-title":"A neonatal mouse model of coxsackievirus A16 for vaccine evaluation","volume":"86","author":"Mao","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.09.069_b0125","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1016\/j.vaccine.2014.05.052","article-title":"A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis","volume":"32","author":"Wu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.069_b0130","doi-asserted-by":"crossref","first-page":"260","DOI":"10.7883\/yoken.66.260","article-title":"Clinical manifestations of coxsackievirus A6 infection associated with a major outbreak of hand, foot, and mouth disease in Japan","volume":"66","author":"Kobayashi","year":"2013","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.09.069_b0135","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.meegid.2017.06.004","article-title":"Synonymous codon usage analysis of hand, foot and mouth disease viruses: a comparative study on coxsackievirus A6, A10, A16, and enterovirus 71 from 2008 to 2015","volume":"53","author":"Su","year":"2017","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2018.09.069_b0140","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jcv.2009.07.019","article-title":"Laboratory investigation and phylogenetic analysis of enteroviruses involved in an aseptic meningitis outbreak in Greece during the summer of 2007","volume":"46","author":"Logotheti","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2018.09.069_b0145","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcv.2011.12.011","article-title":"Detection of coxsackievirus A10 in multiple tissues of a fatal infant sepsis case","volume":"53","author":"Fuschino","year":"2012","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2018.09.069_b0150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00430-016-0465-y","article-title":"Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy","volume":"205","author":"Aswathyraj","year":"2016","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2018.09.069_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2016.73","article-title":"EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases","volume":"5","author":"Mao","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2018.09.069_b0160","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","article-title":"Evaluation of interferences between dengue vaccine serotypes in a monkey model","volume":"80","author":"Guy","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2018.09.069_b0165","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/infdis\/jir279","article-title":"Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate","volume":"204","author":"Anderson","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.09.069_b0170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2016.02.008","article-title":"Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles","volume":"129","author":"Liu","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2018.09.069_b0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.antiviral.2016.08.025","article-title":"neonatal mouse model for the evaluation of antibodies and vaccines against coxsackievirus A6","volume":"134","author":"Yang","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2018.09.069_b0180","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1016\/j.vaccine.2016.08.033","article-title":"Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge","volume":"34","author":"Shen","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.069_b0185","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.antiviral.2017.06.008","article-title":"A neonatal mouse model of coxsackievirus A10 infection for anti-viral evaluation","volume":"144","author":"Li","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2018.09.069_b0190","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.09.069_b0195","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2018.09.069_b0200","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/eji.200838336","article-title":"Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication","volume":"38","author":"Ciuffreda","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2018.09.069_b0205","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1479-0556-5-6","article-title":"DNA Vaccine constructs against enterovirus 71 elicit immune response in mice","volume":"5","author":"Tung","year":"2007","journal-title":"Genet Vacc Ther"},{"key":"10.1016\/j.vaccine.2018.09.069_b0210","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0264-410X(01)00385-1","article-title":"Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus","volume":"20","author":"Wu","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.069_b0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.immunol.021908.132625","article-title":"Immunity to respiratory viruses","volume":"27","author":"Kohlmeier","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2018.09.069_b0220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0092-1157(88)90014-5","article-title":"Interference between strains in live virus vaccines. I. Combined vaccination with measles, mumps and rubella vaccine","volume":"16","author":"Berger","year":"1988","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2018.09.069_b0225","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0092-1157(88)90015-7","article-title":"Interference between strains in live virus vaccines. II. Combined vaccination with varicella and measles\u2013mumps\u2013rubella vaccine","volume":"16","author":"Berger","year":"1988","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2018.09.069_b0230","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.vaccine.2011.01.094","article-title":"Formaldehyde-inactivated human enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine","volume":"29","author":"Chen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.069_b0235","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/15321819.2011.559297","article-title":"Cross-reactivity of anti-EV71 IgM and neutralizing antibody in series sera of patients infected with Enterovirus 71 and Coxsackievirus A 16","volume":"32","author":"Lin","year":"2011","journal-title":"J Immunoassay Immunochem"},{"key":"10.1016\/j.vaccine.2018.09.069_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079783","article-title":"Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers","volume":"8","author":"Chou","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.09.069_b0245","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1128\/CDLI.1.3.336-341.1994","article-title":"Molecular basis for serological cross-reactivity between enteroviruses","volume":"1","author":"Samuelson","year":"1994","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2018.09.069_b0250","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1099\/0022-1317-77-9-2097","article-title":"A study of the cellular immune response to enteroviruses in humans: identification of cross-reactive T cell epitopes on the structural proteins of enteroviruses","volume":"77","author":"Cello","year":"1996","journal-title":"J Gen Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18313501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18313501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T19:32:49Z","timestamp":1605209569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18313501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":50,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0264410X18313501"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}